A Stanford researcher has designed an artificial lens capsule as a drug delivery device inserted at the time of cataract surgery, to address issues of extended drug delivery to the eye with minimal complications.
Active manipulation of light beams is required for a range of emerging optical technologies, including sensing, optical computing, virtual/augmented reality, dynamic holography, and computational imaging.
Researchers at Stanford University have developed Schottky contacts for aluminum nitride-based microelectronic devices. The contacts enable reliable device operation at up to 600 ºC, opening up opportunities for high temperature microelectronic performance.
Stanford researchers have identified exercise-inducible, carboxylesterase 2 (CES2) proteins, which suppress obesity in high fat diet-fed mouse models. Generally, CES2 proteins are intracellular and localized to the endoplasmic reticulum.
Wound healing is a huge clinical problem. Problematic outcomes of skin wounds can range from under-healing (e.g., chronic/non-healing wounds) to over-healing (e.g., scarring).
Stanford researchers in Zhenan Bao's Group have developed a nanomesh sensor printed directly on the hand that uses an AI-trained model to detect multiple movement types from a single sensor.
Stanford scientists have developed broadly neutralizing antibodies against sarbecoviruses , including SARS-CoV-2 related Clade 1b, SARS-CoV related Clade 1a and Clade 3 viruses, paving the way for future vaccines and therapeutics.
Stanford inventors have devised a method of multiplexing droplet reactions to analyze and identify many reactions in parallel on a single microfluidic chip using off-the-shelf flow control and valving.
Researchers at Stanford University have developed a novel method for the first time to generate cardiac pericytes from human induced pluripotent stem cells that closely resemble primary cells.
Stanford scientist has developed a computational method that extracts quantitative imaging features that reproducibly describe lesion phenotypes associated with treatment response and clinical outcomes in cancer.
Researchers in Prof. Karl Deisseroth's laboratory have patented a revolutionary technique that can be utilized to map neural circuits in the whole brain.
Stanford researchers have developed a method to target and lower alpha-synuclein, a major protein constituent of Lewy bodies that accumulate in the brain in Parkinson's disease, using viral gene transfer of mutant Cas9 coupled with a small guide RNA targeting the promoter regi